FDA Drug Shortage Database
Etomidate (Amidate) shortage
The FDA Drug Shortage Database lists 3 of 18 etomidate presentations as limited or unavailable (updated October 5, 2026); the first entry was posted on October 5, 2022. 15 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 2mg/1ml injection | 0 | 12 | 0 |
| 2mg/ml injection | 1 | 3 | 0 |
| 20mg/10ml injection | 1 | 0 | 0 |
| 40mg/20ml injection | 1 | 0 | 0 |
Which presentations are listed?
Limited or unavailable now (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | Hospira, Inc., a Pfizer Company | Current posted October 5, 2022, updated August 24, 2026 | Unavailable; Other |
| Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Eugia US LLC | Current posted October 5, 2022, updated October 2, 2026 | Unavailable; Demand increase for the drug |
| Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Eugia US LLC | Current posted October 5, 2022, updated October 2, 2026 | Unavailable; Demand increase for the drug |
Listed now, available (15)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Hospira, Inc., a Pfizer Company | Current posted October 5, 2022, updated September 22, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Hikma Pharmaceuticals USA, Inc. | Current posted October 5, 2022, updated September 18, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Hikma Pharmaceuticals USA, Inc. | Current posted October 5, 2022, updated September 18, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Hikma Pharmaceuticals USA, Inc. | Current posted October 5, 2022, updated September 18, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Hikma Pharmaceuticals USA, Inc. | Current posted October 5, 2022, updated September 18, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Mylan Institutional, a Viatris Company | Current posted October 5, 2022, updated September 17, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Mylan Institutional, a Viatris Company | Current posted October 5, 2022, updated October 5, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Gland Pharma Limited | Current posted October 5, 2022, updated July 22, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Gland Pharma Limited | Current posted October 5, 2022, updated July 22, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Hikma Pharmaceuticals USA, Inc. | Current posted October 5, 2022, updated September 18, 2026 | Available |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Hikma Pharmaceuticals USA, Inc. | Current posted October 5, 2022, updated September 18, 2026 | Available |
| Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) | Caplin Steriles, Ltd. | Current posted October 5, 2022, updated June 16, 2026 | Available |
| Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) | Caplin Steriles, Ltd. | Current posted October 5, 2022, updated June 16, 2026 | Available |
| Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10) | Caplin Steriles, Ltd. | Current posted October 5, 2022, updated June 16, 2026 | Available |
| Etomidate, Injection, 2mg/mL (NDC 65219-447-20) | Caplin Steriles, Ltd. | Current posted October 5, 2022, updated June 16, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage